Cargando…
Clinical characteristics and health‐care resource utilization in patients with generalized pustular psoriasis using real‐world evidence from the Japanese Medical Data Center database
Little is known about the disease burden, health‐care resource utilization (HCRU), or treatment of patients with generalized pustular psoriasis (GPP) in Japan. This retrospective cohort study used data from the Japanese Medical Data Center database to compare the demographics, comorbidities, and med...
Autores principales: | Okubo, Yukari, Kotowsky, Nirali, Gao, Ran, Saito, Kumiko, Morita, Akimichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290031/ https://www.ncbi.nlm.nih.gov/pubmed/34390028 http://dx.doi.org/10.1111/1346-8138.16084 |
Ejemplares similares
-
Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database
por: Morita, Akimichi, et al.
Publicado: (2021) -
Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis
por: Morita, Akimichi, et al.
Publicado: (2021) -
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180‐week follow‐up results from the phase 3, multicenter IMMspire study
por: Yamanaka, Keiichi, et al.
Publicado: (2022) -
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey
por: Reisner, Dale V., et al.
Publicado: (2022) -
Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results
por: Okubo, Yukari, et al.
Publicado: (2022)